author-photo

Stephanie Greene

Newbury College

3

Papers

174

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

A phase 1/2 trial of ORIN1001, a first-in-class IRE1 inhibitor, in patients with advanced solid tumors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

2019 Nature Communications
Show All
- Source
- Cite
- Save
Citations (69)
Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy

2018 Nature Communications
Show All
- Source
- Cite
- Save
Citations (105)